Base editor treats progeria in mice

Access options

doi: https://doi.org/10.1038/d41586-021-01114-8


  1. 1.

    Eriksson, M. et al. Nature 423, 293–298 (2003).

    PubMed  Article  Google Scholar 

  2. 2.

    De Sandre-Giovannoli, A. et al. Science 300, 2055 (2003).

    PubMed  Article  Google Scholar 

  3. 3.

    Gordon, L. B., Brown, W. T. & Collins, F. S. Hutchinson–Gilford Progeria Syndrome (GeneReviews, 2019).

    Google Scholar 

  4. 4.

    Gordon, L. B. et al. Proc. Natl Acad. Sci. USA 109, 16666–16671 (2012).

    PubMed  Article  Google Scholar 

  5. 5.

    Gaudelli, N. M. et al. Nature 551, 464–471 (2017).

    PubMed  Article  Google Scholar 

  6. 6.

    Anzalone, A. V., Koblan, L. W. & Liu, D. R. Nature Biotechnol. 38, 824–844 (2020).

    PubMed  Article  Google Scholar 

  7. 7.

    Grimm, D. & Zolotukhin, S. Mol. Ther. 23, 1819–1831 (2015).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants and Editas Medicine, companies that use genome editing.


Nature Careers


Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing